MSD's Keytruda doubles PFS in bowel cancer subset

28th May 2020 Uncategorised 0

The ‘game-changing’ results will likely result in a paradigm shift in current clinical practice, researchers said

More: MSD's Keytruda doubles PFS in bowel cancer subset
Source: News